Table 4 The subgroup analysis of the relationship between NHHR and risk of MACCEs

Sex

0.830

Female

1(Ref)

0.78 (0.35,1.76)

0.79 (0.35,1.77)

1.41 (0.65,3.05)

1.43 (0.66,3.1)

Male

1(Ref)

0.79 (0.49,1.29)

0.57 (0.34,0.97)

0.9 (0.56,1.44)

1.05 (0.66,1.68)

Age, years

0.294

<65

1(Ref)

1.02 (0.56,1.80)

1.01 (0.55,1.85)

1.45 (0.83,2.53)

1.47 (0.85,2.55)

≥ 65

1(Ref)

0.64 (0.35,1.17)

0.40 (0.20,0.78)

0.67 (0.36,1.26)

0.92 (0.49,1.73)

Clinical presentation

0.690

STEMI

1(Ref)

1.42 (0.61,3.27)

0.56 (0.22,1.41)

1.03 (0.44,2.41)

1.25 (0.53,2.93)

SA

1(Ref)

0.53 (0.18,1.56)

0.49 (0.15,1.58)

0.96 (0.34,2.66)

1.05 (0.36,3.06)

NSTE-ACS

1(Ref)

0.67 (0.38,1.18)

0.71 (0.41,1.25)

1.02 (0.61,1.72)

1.16 (0.69,1.94)

Smoking status

0.934

No

1(Ref)

0.8 (0.48,1.32)

0.63 (0.37,1.07)

1.08 (0.66,1.75)

1.23 (0.76,1.99)

Yes

1(Ref)

0.83 (0.40,1.74)

0.63 (0.29,1.37)

0.85 (0.42,1.74)

0.99 (0.49,2.00)

Hypertension

0.635

No

1(Ref)

0.84 (0.46,1.51)

0.55 (0.29,1.05)

1.21 (0.69,2.13)

1.07 (0.59,1.93)

Yes

1(Ref)

0.77 (0.43,1.39)

0.72 (0.39,1.31)

0.87 (0.49,1.55)

1.21 (0.70,2.09)

Diabetes

0.858

No

1(Ref)

0.72 (0.45,1.15)

0.62 (0.38,1.02)

0.98 (0.63,1.54)

1.14 (0.73,1.79)

Yes

1(Ref)

1.33 (0.52,3.36)

0.82 (0.31,2.13)

1.02 (0.41,2.53)

1.35 (0.56,3.25)

Heart failure

0.576

No

1(Ref)

0.71 (0.45,1.13)

0.59 (0.37,0.95)

1.02 (0.67,1.56)

1.08 (0.71,1.65)

Yes

1(Ref)

1.34 (0.47,3.81)

1.01 (0.34,3.04)

0.86 (0.26,2.83)

1.56 (0.51,4.77)

CTO

0.133

No

1(Ref)

0.91 (0.58,1.43)

0.79 (0.50,1.26)

1.17 (0.76,1.82)

1.33 (0.86,2.06)

Yes

1(Ref)

0.40 (0.13,1.27)

0.11 (0.03,0.46)

0.44 (0.14,1.34)

0.54 (0.16,1.43)